A quality control engineer at a pharmaceutical company monitors the production of vaccine vials. Historical data shows that
3% of vials have a contamination defect. The company uses a two-stage screening process.
- First stage: an automated optical inspection detects
90% of contaminated vials but incorrectly flags
2% of clean vials as contaminated. Flagged vials are rejected; unflagged vials pass to the second stage.
- Second stage: a chemical test, performed only on vials that passed the first stage, correctly identifies
98% of contaminated vials and correctly clears
99% of clean vials. Vials identified as contaminated in this stage are rejected; all others are released.